Thiago Jordao da Silva Lemos

Mr. Thiago Jordao da Silva Lemos

NeuroLinkStation - NLS Biotech, São Paulo, Brazil
orcid
CEO - NeuroLinkStation co.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Toxicon
Verified
Journal Article
Closed access
MDMarta de Oliveira Domingos
Marta de Oliveira Domingos
INIrys Viana Neves
Irys Viana Neves
HVHugo Vigerelli
Hugo Vigerelli
Daniel Carvalho PimentaDaniel Carvalho Pimenta
Daniel Carvalho Pimenta
BTBianca Távora
Bianca Távora
KBKatia Cristina Barbaro
Katia Cristina Barbaro

Verified
Journal Article
Open access
PDF file
Thiago Jordao da Silva LemosThiago Jordao da Silva Lemos
Thiago Jordao da Silva Lemos
HSHerbert Guimarães de Sousa Silva
Herbert Guimarães de Sousa Silva
JPJosé Osvaldo Previato
José Osvaldo Previato
LMLucia Mendonça-Previato
Lucia Mendonça-Previato
EFElisangela Oliveira de Freitas
Elisangela Oliveira de Freitas
MDMarta de Oliveira Domingos
Marta de Oliveira Domingos
Enteropathogenic Escherichia coli (EPEC) produce a capsule of polysaccharides identical to those composing the O-antigen polysaccharide of its LPS (lipopolysaccharide) molecules. In light of this, the impact of O26 polysaccharides on the immune evasion mechanisms of capsulated O26 EPEC compared to non-capsulated enterohemorrhagic Escherichia coli (EHEC) was investigated. Our findings reveal that there was no significant difference between the levels in EPEC and EHEC of rhamnose (2.8:2.5), a molecule considered to be a PAMP (Pathogen Associated Molecular Patterns). However, the levels of glucose (10:1.69), heptose (3.6:0.89) and N-acetylglucosamine (4.5:2.10), were significantly higher in EPEC than EHEC, respectively. It was also observed that the presence of a capsule in EPEC inhibited the deposition of C3b on the bacterial surface and protected the pathogen against lysis by the complement system. In addition, the presence of a capsule also protected EPEC against phagocytosis by macrophages. However, the immune evasion provided by the capsule was overcome in the presence of anti-O26 polysaccharide antibodies, and additionally, these antibodies were able to inhibit O26 EPEC adhesion to human epithelial cells. Finally, the results indicate that O26 polysaccharides can generate an effective humoral immune response, making them promising antigens for the development of a vaccine against capsulated O26 E. coli.
1

19 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Thiago Jordao da Silva LemosThiago Jordao da Silva Lemos
Thiago Jordao da Silva Lemos
HSHerbert Guimarães de Sousa Silva
Herbert Guimarães de Sousa Silva
JPJosé Osvaldo Previato
José Osvaldo Previato
LMLucia Mendonça-Previato
Lucia Mendonça-Previato
EFElisangela Oliveira de Freita
Elisangela Oliveira de Freita
MDMarta de Oliveira Domingos
Marta de Oliveira Domingos
O26 enteropathogenic Escherichia coli (EPEC), possesses a unique pseudocapsule composed of polysaccharides identical to the O antigen in their lipopolysaccharide (LPS) membrane. Therefore, the impact of O26 polysaccharides on the immune evasion mechanisms of capsulated O26 EPEC was investigated. Our findings reveal that the concentration of GlcNAc, an immunodominant unit of O26 polysaccharides capable of activating the MBL (Mannose Biding Lecting) pathway of the complement system, was found to be lower in capsulated EPEC O26 compared to naked shiga toxin-producing E. coli (STEC) O26 strain. It was noted that, unlike the naked STEC strain, the capsulated EPEC O26 strain was protected against lysis by the alternative pathway of the com-plement system by inhibiting C3b adhesion to its bacterial surface. Capsulated EPEC O26 strains were also able to avoid phagocytosis by macrophages. However, the immune evasion provided by the capsule was overcome in the presence of anti-O26 polysaccharide antibodies. Additionally, these antibodies were able to recognize O26 EPEC in the presence of biofilm and inhibit their adhesion to human epithelial cells. Overall, the results indicate that the O26 polysaccharides can generate an effective humoral immune response, making them promising antigens for the de-velopment of a vaccine against capsulated O26 E. coli
1

1 May 2016 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
Thiago Jordao da Silva LemosThiago Jordao da Silva Lemos
Thiago Jordao da Silva Lemos
1

28 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Thiago Jordao da Silva LemosThiago Jordao da Silva Lemos
Thiago Jordao da Silva Lemos
Mario Antonio ZanettiMario Antonio Zanetti
Mario Antonio Zanetti
Universal health access depends not only on the existence of biomedical innovations but also on the institutional and economic chain that connects research financing to production, regulation, procurement, distribution, and implementation. This essay examines how geopolitical and fiscal conditions can shape that conversion. A structured critical review of 70 multidisciplinary sources was used to integrate evidence on science funding, development assistance for health, global governance, intellectual property, pharmaceutical pricing, vaccine manufacturing, supply security, universal health coverage, the Brazilian Unified Health System (Sistema Único de Saúde, SUS), and the Health Economic-Industrial Complex. The synthesis organizes the science-to-access pathway into interdependent functions spanning priority setting, research and development financing, production or procurement capacity, regulation and negotiation, distribution and implementation, and effective population access. Across these functions, the evidence indicates that scientific capacity is necessary but insufficient: fiscal space, supplier concentration, bargaining power, regulatory and industrial capacity, logistics, and territorial inequalities can alter whether innovation becomes sustainably available. The SUS illustrates how legal universality and large-scale public purchasing can coexist with financing constraints, regional inequalities, and productive dependence. The article therefore proposes that supply security, total implementation cost, absorptive capacity, and distributive effects should be incorporated into the assessment of health innovation from the stage at which scientific priorities are defined. The framework is intended to support context-sensitive analysis rather than a universal policy prescription and identifies a research agenda for empirically testing links among science funding, production strategies, resilience, and equitable access.
2

20 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Thiago Jordao da Silva LemosThiago Jordao da Silva Lemos
Thiago Jordao da Silva Lemos
Mario Antonio ZanettiMario Antonio Zanetti
Mario Antonio Zanetti
A false proposition can coexist with a documented historical act of asserting it. Digital interventions that limit harmful circulation therefore raise a distinct question: what contextual relationships should remain recoverable when the evaluated material becomes unavailable? This theoretical essay develops Contextualized Epistemic Preservation (PEC), a framework for retaining a proportionate, revisable relationship among an informational occurrence, its assessment, supporting evidence, provenance and subsequent corrections. The approach combines conceptual analysis, purposive narrative engagement with interdisciplinary literature and institutional documents, and a temporal thought experiment termed the 2035 Paradox. The scenario examines the possible asymmetric survival of misleading fragments and the contextual records needed to evaluate them. The framework distinguishes factual assessment from documentary authenticity, institutional disposition, public exposure and computational retrieval. It specifies a layered record architecture, a substitution test for selecting safer representations, differentiated governance safeguards, and an empirical agenda containing seven hypotheses and six candidate metrics. Preservation, public indexing, recommendation, restricted access and destruction are treated as distinct operations. The proposed benefits remain conditional: persistent records may facilitate verification but may also reproduce harm, entrench erroneous classifications or impose unjustified maintenance costs. No PEC implementation or experiment is reported. The contribution is an auditable design proposal for preserving the history of evaluation under proportionate protections; its effectiveness, feasibility and comparative value require empirical testing.
1